153 results on '"Jin Shan"'
Search Results
2. Letter by Jin-shan and Xue-bin Regarding Article, “Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis”
3. Letter by Jin-shan and Xue-bin Regarding Article, “Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)”
4. Letter by Jin-shan and Xue-bin Regarding Article, “A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure”
5. Letter by Jin-shan and Xue-bin Regarding Article, “Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study”
6. Letter by Jin-shan and Xue-bin Regarding Article, “Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)”
7. Letter by Jin-shan and Xue-bin Regarding Article, “Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise”
8. Letter by Jin-shan and Xue-bin Regarding Article, “Idiopathic Ventricular Fibrillation in a 29-Year-Old Man”
9. Letter by Jin-shan and Xue-bin Regarding Article, “Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile”
10. Letter by Jin-shan and Xue-bin Regarding Article, “Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction”
11. Letter by Jin-shan and Xue-bin Regarding Article, “Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplantation”
12. Letter by Jin-shan and Xue-bin Regarding Article, “Loss of Cardioprotective Effects at the ADAMTS7 Locus as a Result of Gene-Smoking Interactions”
13. Letter by Jin-Shan and Xue-Bin Regarding Article, “Out-of-Hospital Cardiac Arrest: An Underlying Reversible Cause”
14. Letter by Jin-Shan and Xue-Bin Regarding Article, “Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)”
15. Letter by Jin-shan and Xue-bin Regarding Article, “Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry”
16. Letter by Jin-shan and Xue-bin Regarding Article, “Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)”
17. Letter by Jin-shan and Xue-bin Regarding Article, “Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement”
18. Letter by Jin-Shan and Xue-Bin Regarding Article, “Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus”
19. Letter by Jin-shan and Xue-bin Regarding Article, “Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])”
20. Letter by Jin-Shan and Xue-Bin Regarding Article, “Fire Simulation and Cardiovascular Health in Firefighters”
21. Letter by Jin-shan and Xue-bin Regarding Article, “Tachycardia-Induced Cardiomyopathy in a 43-Year-Old Man”
22. Letter by Jin-shan and Xue-bin Regarding Article, 'Platelets Express Activated P2Y
23. Letter by Jin-shan and Xue-bin Regarding Article, 'Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?'
24. Letter by Jin-shan and Xue-bin Regarding Article, 'Loss of Cardioprotective Effects at the ADAMTS7 Locus as a Result of Gene-Smoking Interactions'
25. Letter by Jin-Shan and Xue-Bin Regarding Article, 'Out-of-Hospital Cardiac Arrest: An Underlying Reversible Cause'
26. Letter by Jin-shan and Xue-bin Regarding Article, 'Idiopathic Ventricular Fibrillation in a 29-Year-Old Man'
27. Letter by Jin-shan and Xue-bin Regarding Article, 'Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry'
28. Letter by Jin-shan and Xue-bin Regarding Article, 'Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)'
29. Letter by Jin-shan and Xue-bin Regarding Article, 'Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement'
30. Letter by Jin-shan and Xue-bin Regarding Article, “Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality”
31. Letter by Jin-shan and Xue-bin Regarding Article, “Chronic Myocardial Infarction: Where Is It Located?“
32. Letter by Jin-shan and Xue-bin Regarding Article, “Platelets Express Activated P2Y 12 Receptor in Patients With Diabetes Mellitus”
33. Letter by Jin-shan and Xue-bin Regarding Article, “Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?”
34. Letter by Jin-shan and Xue-bin Regarding Article, “Worsening Conduction Delay in Hypertrophic Cardiomyopathy: What Drug Is Responsible?”
35. Letter by Jin-shan and Xue-bin Regarding Article, "Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement".
36. Letter by Jin-Shan and Xue-Bin Regarding Article, 'Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus'
37. Letter by Jin-shan and Xue-bin Regarding Article, 'Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])'
38. Letter by Jin-Shan and Xue-Bin Regarding Article, 'Fire Simulation and Cardiovascular Health in Firefighters'
39. Letter by Jin-shan and Xue-bin Regarding Article, 'Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality'
40. Letter by Jin-shan and Xue-bin Regarding Article, 'Chronic Myocardial Infarction: Where Is It Located?'
41. Letter by Jin-shan and Xue-bin Regarding Article, 'Cardioprotective Role of Tumor Necrosis Factor Receptor-Associated Factor 2 by Suppressing Apoptosis and Necroptosis'
42. Letter by Jin-shan and Xue-bin Regarding Article, 'Worsening Conduction Delay in Hypertrophic Cardiomyopathy: What Drug Is Responsible?'
43. Letter by Jin-shan and Xue-bin Regarding Article, 'Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis'
44. Letter by Jin-shan and Xue-bin Regarding Article, 'Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)'
45. Letter by Jin-shan and Xue-bin Regarding Article, 'A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure'
46. Letter by Jin-shan and Xue-bin Regarding Article, 'Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study'
47. Letter by Jin-shan and Xue-bin Regarding Article, 'Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)'
48. Letter by Jin-shan and Xue-bin Regarding Article, 'Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise'
49. Letter by Jin-shan and Xue-bin Regarding Article, 'Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile'
50. Letter by Jin-shan and Xue-bin Regarding Article, 'Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction'
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.